SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
SUMMARY: Objectives: We sought to understand the spread of SARS-CoV-2 infection in urban India, which has surprisingly low COVID-19 deaths. Design: Cross-sectional and trend analyses of seroprevalence in self-referred test populations, and of reported cases and COVID mortality data. Participants: 448,518 self-referred individuals using a nationwide chain of private laboratories with central testing of SARS-CoV-2 antibodies and publicly available case and mortality data. Setting: 12 populous cities with nearly 92 million total population. Main outcome measures: Seropositivity trends and predictors (using a Bayesian geospatial model) and prevalence derived from mortality data and infection fatality rates (IFR). Results: For the whole of India, 31% of the self-referred individuals undergoing antibody testing were seropositive for SARS-CoV-2 antibodies. Seropositivity was higher in females (35%) than in males (30%) overall and in nearly every age group. In these 12 cities, seroprevalence rose from about 18% in July to 41% by December, with steeper increases at ages <20 and 20-44 years than at older ages. The “M-shaped” age pattern is consistent with intergenerational transmission. Areas of higher childhood measles vaccination in earlier years had lower seropositivity. The patterns of increase in seropositivity and in peak cases and deaths varied substantially across cities. In Delhi, death rates and cases first peaked in June and again in November; Chennai had a single peak in July. Based local IFRs and COVID deaths (adjusted for undercounts), we estimate that 43%-65% of adults above age 20 had been infected (range of mid-estimates of 12%-77%) corresponding 26 to 36 million infected adults in these cities, or an average of 9-12 infected adults per confirmed case. Conclusion: Even with relatively low death rates, the large cities of India had remarkably high levels of SARS-CoV-2 infection. Vaccination strategies need to consider widespread intergenerational transmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, a variation in overall seroprevalence in children, adults, and the generalised population is noted across national, regional, and local studies [63–66].”
From Impact of COVID-19 on life expectancy at birth in India: a decomposition analysis (2021) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Age-specific mortality and immunity patterns of SARS-CoV-2
O’Driscoll, M., Ribeiro Dos Santos, G., Wang, L., Cummings, D. A. T., Azman, A. S., Paireau, J., Fontanet, A., Cauchemez, S., & Salje, H. (2021) · Nature · doi:10.1038/s41586-020-2918-0 · Cited by 1,210
Walker, P. G. T., Whittaker, C., Watson, O. J., Baguelin, M., Winskill, P., Hamlet, A., Djafaara, B. A., Cucunubá, Z., Olivera Mesa, D., Green, W., et al. (2020) · Science · doi:10.1126/science.abc0035 · Cited by 993
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
Lumley, S. F., O’Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034545 · Cited by 940
Levin, A. T., Hanage, W. P., Owusu-Boaitey, N., Cochran, K. B., Walsh, S. P., & Meyerowitz-Katz, G. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00698-1 · Cited by 844
The non-specific and sex-differential effects of vaccines
Aaby, P., Benn, C. S., Flanagan, K. L., Klein, S. L., Kollmann, T. R., Lynn, D. J., & Shann, F. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0338-x · Cited by 142
Research works printed but not linked: 23
- Brown P , Rai K , La Vecchia C , et al. Mortality from COVID-19 in 12 countries and 6 states of the United States. medRxiv 2020. doi: https://doi.org/10.1101/2020.04.17.20069161. Available from https://covid.cghr.dev/. · doi:10.1101/2020.04.17.20069161
- 10.1016/S2214-109X(19)30451-6 · DOI · Paper page
- 2021, High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?, Epidemiology and Infection, 149, e39., 10.1017/S0950268821000273 · DOI
- 10.1016/S2214-109X(20)30467-8 · DOI · Paper page
- Ghose A , Bhattacharya S , Karthikeyan AS , et al. Community prevalence of antibodies to SARS-CoV-2 and correlates of protective immunity in five localities in an Indian metropolitan city. medRxiv 2020 Dec. doi: https://doi.org/10.1101/2020.11.17.20228155 · DOI
- 10.1001/jama.2021.0332 · DOI
- 10.1007/s10668-020-00878-9 · DOI · Paper page
- 2020, COVID-19 seroprevalence study of an Indian Diagnostic Laboratory-Report on gender and age analysis, Asian Journal of Health Sciences, 6, 16
- 2020, Income distribution and inequality in India: 2014-19. arXiv preprint
- Hammer MS , van Donkelaar A , Li C , et al. Global Estimates and Long-Term Trends of Fine Particulate Matter Concentrations (1998-2018). Environmental Science & Technology. 2020 Jun 3. doi: https://pubs.acs.org/doi/10.1021/acs.est.0c01764 · DOI · Paper page
- WorldPop and Center for International Earth Science Information Network (CIESIN), Columbia University (2018). Global High Resolution Population Denominators Project. doi: https://dx.doi.org/10.5258/SOTON/WP00649 · doi:10.5258/soton/wp00649
- 2015, Model-based geostatistics the easy way. Journal of Statistical Software, 63, 1
- 2020, SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys, The Lancet Global Health, 8, e1390, 10.1016/S2214-109X(20)30387-9 · DOI · Paper page
- 10.1016/S1473-3099(20)30858-6 · DOI · Paper page
- 2015, One-person households in India, Demographic Research, 32, 1239, 10.4054/DemRes.2015.32.45 · DOI
- 2021, SARS-CoV-2 antibody seroprevalence in India, August– September, 2020: findings from the second nationwide household serosurvey, The Lancet Global Health, 9, e257, 10.1016/S2214-109X(20)30544-1 · DOI · Paper page
- 2020, Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis, PLoS Med, 17, 21003346
- Byambasuren O , Cardona M , Bell K , Clark J , McLaws ML , Glasziou P. Estimating the extent of asymptomatic covid-19 and its potential for community transmission: Systematic review and meta-analysis, Off. J. Assoc. Med. Microbiol. Infect. Dis. Canada COVID-19, e20200030 (2020) · DOI
- 2021, Infectivity of asymptomatic versus symptomatic COVID-19, The Lancet, 397, 93, 10.1016/S0140-6736(20)32651-9 · DOI · Paper page
- 10.1126/science.abc4262 · DOI
- 10.1136/bmj.m3018 · DOI
- 10.1016/S2214-109X(19)30451-6 · DOI · Paper page
- 2020, Defining the Epidemiology of Covid-19 – Studies Needed, New England Journal of Medicine, 382, 1194, 10.1056/NEJMp2002125 · DOI · Paper page
Cited by
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Mlcochova, P., Kemp, S. A., Dhar, M. S., Papa, G., Meng, B., Ferreira, I. A. T. M., Datir, R., Collier, D. A., Albecka, A., Singh, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03944-y · Cited by 1,337
Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Dhar, M. S., Marwal, R., Radhakrishnan, V., Ponnusamy, K., Jolly, B., Bhoyar, R. C., Sardana, V., Naushin, S., Rophina, M., Mellan, T. A., et al. (2021) · doi:10.1101/2021.06.02.21258076 · Cited by 296
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Dhar, M. S., Marwal, R., VS, R., Ponnusamy, K., Jolly, B., Bhoyar, R. C., Sardana, V., Naushin, S., Rophina, M., Mellan, T. A., et al. (2021) · Science · doi:10.1126/science.abj9932 · Cited by 296
COVID mortality in India: National survey data and health facility deaths
Jha, P., Deshmukh, Y., Tumbe, C., Suraweera, W., Bhowmick, A., Sharma, S., Novosad, P., Fu, S. H., Newcombe, L., Gelband, H., et al. (2022) · Science · doi:10.1126/science.abm5154 · Cited by 172
Self-citationImpact of COVID-19 on life expectancy at birth in India: a decomposition analysis
Yadav, S., Yadav, P. K., & Yadav, N. (2021) · BMC Public Health · doi:10.1186/s12889-021-11690-z · Cited by 32
Metadata
- Authors
- Velumani, A., Nikam, C., Suraweera, W., Fu, S. H., Gelband, H., Brown, P., Bogoch, I., Nagelkerke, N., & Jha, P.
- Publisher
- openRxiv
- Published
- 2021-03-24
- Cited by
- 15
- References
- 5
- Type
- Preprint
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020. https://app.cochat.ai/papers/10.1101/2021.03.19.21253429
- The paper
- Velumani, A., Nikam, C., Suraweera, W., Fu, S. H., Gelband, H., Brown, P., Bogoch, I., Nagelkerke, N., & Jha, P. (2021). SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020. https://doi.org/10.1101/2021.03.19.21253429
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.